Categories
Health

Some Lengthy Covid-19 Sufferers Really feel Higher After Vaccine Doses

A survey of 345 people, mostly women and mostly in the UK, found that two weeks or more after their first dose of vaccine, 93 felt slightly better and 18 felt normal again – a total of 32 percent reported improved long-term Covid symptoms.

In this survey by Gez Medinger, a London-based filmmaker who experienced post-Covid symptoms, 61 people, just under 18 percent, felt worse. Most of them reported only a slight decrease in their condition. Almost half – 172 people – said they didn’t feel any different.

Another survey by the Survivor Corps, a group of over 150,000 Covid survivors, found that on March 17, 225 out of 577 respondents reported some improvement, while 270 felt no change and 82 felt worse.

Jim Golen, 55, of Saginaw, Minnesota, believes some long-term Covid symptoms have worsened since he was vaccinated. Mr. Golen, a former hospice nurse who also has a small farm, has had months of trouble including blood clots in the lungs, chest pain, brain fog, insomnia, and shortness of breath with every effort. At the end of last year, after seeing several doctors, “I finally felt better,” he said.

Since receiving the second dose of the Pfizer vaccine in mid-January, his chest soreness and shortness of breath have returned with a vengeance, especially when taxing himself on activities like collecting sap from maple trees on his farm. Even so, Mr Golen said he was “very happy” to be vaccinated, stressing that the effects of Covid were worse and that it was crucial to prevent it.

Categories
Business

U.S. tops 100 million Covid vaccine doses given, 13% of adults absolutely vaccinated

Residents wait in line to be vaccinated on March 10, 2021 in Chicago, Illinois at a COVID-19 mass vaccination center set up in a parking lot outside the United Center, home of the Chicago Bulls and Blackhawks.

Scott Olson | Getty Images

The U.S. exceeded 100 million Covid-19 vaccine doses administered on Friday, according to the Centers for Disease Control and Prevention.

About 35 million people have been fully vaccinated, which is 13.5% of the adult US population, according to the CDC. About 65.9 million people have received at least one intake of two-dose therapy, the CDC said.

The milestone includes the 16.5 million vaccines administered under the Trump administration, but brings President Joe Biden closer to his goal of getting 100 million shots in his arms in his first 100 days in office.

Of those 65 and older, more than 32% are fully vaccinated and over 61% have received at least one dose, according to the CDC. This is noteworthy in that roughly 80% of the deaths caused by Covid-19 in the United States were in people aged 65 and over.

The government has gradually accelerated the pace of vaccinations since Biden took office. The White House originally attempted to administer 1 million shots a day, which some public health specialists criticized as a low target. The US hit a record 2.9 million shots on Friday, according to the CDC.

There are now three Covid-19 vaccines that have received emergency approval from the Food and Drug Administration. Moderna and Pfizer’s two-dose emergency vaccines were approved in December, and Johnson & Johnson’s single vaccine was approved last month.

The White House has worked with manufacturers to speed up production and increase the overall supply of shots for the U.S. On Wednesday, Biden announced that the government plans to source an additional 100 million doses of the J&J vaccine.

J&J currently has a contract with the U.S. government to provide 100 million cans by the end of June, though White House officials said this week the company can deliver those cans by the end of May. This is thanks to a deal where J&J rival Merck will help make vaccine doses, Jeff Zients, the White House’s Covid-19 responses coordinator, told a news conference Friday.

Zients added that Moderna and Pfizer are expected to each deliver 200 million doses of their vaccines by the end of May.

“That’s more than enough vaccine to keep all adult Americans vaccinated by the end of May,” Zients said. “Now we need to increase the number of vaccines we’ve talked about and the number of places that Americans can be vaccinated.”

Biden used his first prime-time address to the nation on Thursday to urge states to question all adults for the Covid vaccines by May 1’s final decision. Alaska began opening the permission before Biden’s speech.

Some public health professionals fear that while the demand for vaccines was high when it was first introduced, the available demand may decline.

In his address on Thursday evening, Biden urged Americans to continue to follow public health measures and get vaccinated when it is their turn. He also aims to allow Americans to meet up in small groups in person with their friends and loved ones to celebrate July Fourth in case the pandemic in the US continues to decline

“If we all do our part, this country will soon be vaccinated, our economy will improve, our children will be back in school and we will prove once again that this country can do everything,” said Biden. But “if we don’t stay vigilant and conditions change, we may have to reintroduce the restrictions to get back on track.”

Correction: This article has been updated to reflect that President Joe Biden has not yet achieved his goal of 100 million vaccine doses in his first 100 days.

Categories
Politics

The U.S. Is Sitting on Tens of Tens of millions of Vaccine Doses the World Wants

“If we have a surplus, we’ll share it with the rest of the world,” Biden told reporters on Wednesday, speaking broadly about US vaccine supplies. “We will first make sure that the Americans are taken care of first.”

Johnson & Johnson, which has US approval for its vaccine but has missed its production targets in both the US and Europe, recently asked the US to loan 10 million doses to the European Union, but the Biden administration this also denied this request to American and European officials.

What you need to know about the vaccine rollout

The European Union has been heavily criticized for “vaccine nationalism” and protectionism, which escalated last week when Italy blocked a small dose delivery to Australia and intensified a tug-of-war over much-needed shots. Still, the European Union has exported 34 million doses of coronavirus vaccines to dozens of countries in the past few weeks despite shortages at home.

As frustrations subside, some European officials blame the United States. European Council President Charles Michel said the United States and Britain had “imposed a total ban on the export of vaccines or vaccine components made on their territory”. Jen Psaki, White House press secretary, was asked Thursday about American delivery of the AstraZeneca vaccine and told reporters that vaccine makers are free to export their US-made products while fulfilling the terms of their contracts with the government .

Since the vaccine was manufactured by AstraZeneca under the Defense Production Act, Mr Biden must authorize the shipment of cans overseas. Such a move could have a huge negative political impact while Americans are still calling for gunfire.

AstraZeneca is also likely to want liability protection for cans shipped overseas, as it would in the US if the vaccine were approved.

In the meantime, regulators in the US have been waiting for new AstraZeneca data, which is expected in the next few weeks from a phase 3 study that enrolled 32,000 participants, mostly in the US. AstraZeneca is unlikely to report results from an early look at its data like other vaccine manufacturers have. Instead, it will wait for more statistically significant results after study participants have been monitored for side effects longer and potentially more people in the vaccine and placebo groups have gotten sick, federal officials said. Experts believe the vaccine is unlikely to be any more potent than the Johnson & Johnson shot, which uses similar technology and only requires one dose.

Categories
Health

Biden Covid staff holds briefing as U.S. plans to purchase extra J&J vaccine doses

[The stream is slated to start at 11 a.m. ET. Please refresh the page if you do not see a player above at that time.]

President Joe Biden’s Covid-19 Response Team holds a press conference Wednesday on the coronavirus pandemic that infected more than 29 million Americans and killed at least 527,720 people in just over a year.

Two government sources told NBC News that the U.S. government plans to buy 100 million additional doses of the Covid-19 vaccine from Johnson & Johnson. Biden will announce the plans on Wednesday during a White House meeting with executives from J&J and Merck.

J&J currently has a contract with the US government to provide 100 million cans by the end of June. The federal government shipped nearly 3.9 million doses of the single vaccine last week and plans to distribute an additional 16 million by the end of this month.

Read CNBC’s live updates for the latest news on the Covid-19 outbreak.

Categories
Business

Biden administration plans to purchase 100 million further doses

Johnson & Johnson’s Janssen COVID-19 vaccine will be stored in Chicago, Illinois for use with United Airlines employees at the United Clinic at O’Hare International Airport on March 9, 2021.

Scott Olson | Getty Images

The US plans to buy an additional 100 million doses of Johnson & Johnson’s Covid-19 vaccine, two government sources told NBC News.

President Joe Biden will announce the plans on Wednesday during a White House meeting with J&J and Merck executives.

J&J currently has a contract with the US government to provide 100 million cans by the end of June. The federal government shipped nearly 3.9 million doses of the single vaccine last week and plans to distribute an additional 16 million by the end of this month.

In a statement, J&J noted that the government’s initial agreement for $ 1 billion worth of 100 million cans in August gave the government the opportunity to purchase additional cans under a later agreement.

“We look forward to future talks with the US government and attending the White House event later today,” the company said in a statement.

The announcement comes as administration is working to ramp up production of J & J’s vaccine after learning earlier this year that the company was lagging behind in vaccine production.

The Food and Drug Administration approved J & J’s vaccine on February 27 for use in people 18 years of age and older. Unlike Pfizer and Moderna vaccines, patients with the single dose of J&J do not need to take a second dose and can be stored at refrigerator temperature for months.

The New York Times first reported in January that unexpected delays in manufacturing would result in decreased primary care of J & J’s medication if it were given emergency approval.

Last week, Biden announced that pharmaceutical company Merck would help manufacture J & J’s Covid vaccine. Under the terms of the agreement, Merck will deploy two facilities in the US for J & J’s vaccine. One will make the vaccine and the other will provide “fill-finish” services when the vaccine is put into vials.

The Department of Health and Human Services said the U.S. would provide Merck with $ 105 million under the Defense Production Act to upgrade, upgrade, and equip the company’s facilities to the standards necessary to safely manufacture the vaccine are.

The Chief Medical Officer of the White House, Dr. Anthony Fauci said last month he was “disappointed” with the number of doses J&J originally expected, adding that the federal government had assumed there would be “significantly more”.

“It can take June, July and August to get everyone vaccinated,” Fauci told CNN on February 16. I don’t think anyone will disagree that this will be good by the end of summer and we’ll get into early fall. “

Categories
Health

Covid-19 Vaccines: Dr. B Web site Will Match You With Leftover Doses

In the rush of getting an elusive vaccine appointment, the leftover dose has become the stuff of the pandemic.

Additional footage to be used within hours of leaving the cold store has been distributed to drugstore customers buying midnight snacks, people who are nurse friends, and people who show up at certain grocery stores and pharmacies at closing time. At some major vaccination sites, the race to use each dose triggers a series of phone calls at the end of the day.

In either case, if the remaining dose cannot find an available arm, it must go to the trash.

Now a New York-based start-up wants to put the rush for leftover cans in order. Dr. B, as the company is called, compares vaccine providers who are receiving additional vaccines with people who are willing to receive them right away.

Since the service began last month, more than 500,000 people have submitted a variety of personal information to sign up for the service, which is free and free for providers too. Two vaccination centers have started testing the program, and the company said about 200 other providers had applied to participate.

Dr. B is just an attempt to coordinate the chaotic patchwork of public and private websites that allow eligible people to find vaccine appointments. Critics said the current system is confusing, unreliable, and often requires access to the Internet and time to search for websites for the infrequent appointment. In many places, people who are not yet eligible for a shot are also largely ignored, missing the opportunity to put them on a formal waiting list.

While Dr. B does not solve all of these broader problems, if it increases the hope that it will, it could serve as a model for better and fairer vaccination planning.

“I think this is a great idea,” said Sharon Whisenand, the administrator for the Randolph County’s Department of Health in rural Missouri.

Ms. Whisenand said 60 to 80 people did not show up for the county’s first mass vaccination event in late January, prompting her staff to make dozens of calls to people on a waiting list at the end of the day. “We sounded a bit like a call center,” she said. The workers eventually found enough buyers to give most of the extra doses, but some shots were thrown away.

Dr. B is a not-for-profit organization founded as a not-for-profit company whose mission is to ensure the efficient and fair distribution of vaccines. But its founder, Cyrus Massoumi, a tech entrepreneur, took Dr. B not yet described. He said he is funding the project out of pocket and has no plans to generate any income. The company is named after his grandfather, nicknamed Dr. Bubba wore and became a doctor during the 1918 pandemic influenza.

Mr. Massoumi is the founder and former CEO of ZocDoc, which helps patients find available doctor appointments, and the founder of Shadow, a company that uses technology and on-site volunteers to bring lost pets together with their owners. Like these two efforts, Dr. B, to make connections between groups who need something from each other.

“Ultimately, patients need this vaccine, and there are providers who need help getting it to the priority people,” Massoumi said in an interview. “That’s my motivation.”

After Mr Massoumi came up with the idea for Dr. B, he recruited several engineers from Haven, a now-defunct healthcare collaboration between Amazon, Berkshire Hathaway and JP Morgan, to build the website and underlying database. Amazon has also donated web services, Massoumi said.

The half a million people who signed up for the service entered basic biographical information such as date of birth, address, underlying health conditions, and the type of work they did. When vaccine providers near you receive additional doses, they will be notified by SMS and have 15 minutes to respond. Then they have to be ready to travel quickly to the vaccination site.

The company’s database sorts people according to local vaccine priority rules, so providers have a better chance of delivering their leftover shots to those most in need.

For many vendors, this proper practice would be a welcome change from the random systems they currently use. At some pharmacies and supermarket chains, workers have combed the aisles to find people ready to get vaccinated at the last minute. Elsewhere, vaccine hopefuls wait in line at the end of each shift, which could pose a risk of infection, especially for the most vulnerable.

Despite some grumbling about younger, healthier people skipping the line by snapping leftover cans, public health experts and many ethicists say the most important thing is that the vaccines don’t go to waste. At the start of the vaccine rollout, some politicians like New York Governor Andrew M. Cuomo threatened sanctions against providers for failing to follow the priority rules exactly, and a doctor in Texas lost his job after giving leaked doses to people with illness including his wife.

For those offered a last minute vaccine, “that person shouldn’t say no because they want it to go to someone else,” said Dr. Shikha Jain, assistant professor of medicine at the University of Illinois, Chicago, and a contributor -founder of IMPACT, a group that worked to improve the fair distribution of vaccines. “However, it’s really important to be deliberate and fair,” she said.

Mr Massoumi said he took several steps to make sure the service was fair. This included turning down early media inquiries from mainstream publications and instead using Dr. B on Zoom calls with representatives from groups such as black churches and Native American community groups, as the pandemic has disproportionately affected non-white groups.

Updated

March 9, 2021, 11:16 p.m. ET

“It was really important to him to put these communities at the top or get the information early,” said Brooke Williams, Black and a member of the Resistance Revival Chorus in New York. She joined one of the early Zoom calls and started spreading the word.

“To hear about gunshots being thrown away was just heartbreaking and annoying,” she said.

However, the service suffers from some of the same obstacles that have hampered vaccination efforts so far. While signing in is easy, it requires an internet connection as well as instant access to a mobile phone. Due to the last minute nature of the leftover cans, attendees need flexible schedules and access to transportation.

“It’s still heavily dependent on the Internet, so it depends on who’s hearing about it,” said Arthur Caplan, a medical ethicist at New York University’s Grossman School of Medicine. “It seems like he’s trying to solve a problem and do something good, but I’m sad that governments – counties, cities, national organizations – didn’t prepare for it and then didn’t respond faster to advice and To give instructions. “

Mr. Massoumi noted that the website allowed people such as community volunteers to sign up on behalf of others. The site is also available in Spanish.

He noted that the setup of the program, which allows users to log in and then wait for a notification in order of priority, is better than other sites that require hours of website updating when there is a chance they are lucky to achieve a rare opening.

What you need to know about the vaccine rollout

Some local health authorities, including Washington, DC and West Virginia, are moving to a similar pre-registration system that can help level the playing field.

“It feels like you don’t know where you are and the only way to save your spot is to update a browser,” said John Brownstein, a researcher at Boston Children’s Hospital, who runs VaccineFinder.org , an online portal that helps people book vaccine appointments.

For Brittany Marsh, who owns a pharmacy in Little Rock, Ark., Figuring out what to do with leftover cans has been a daily problem.

She said the number of no-shows had increased as vaccines became more available and others had to cancel at the last minute because they developed Covid-19 or were exposed to someone who did. Although sometimes people call, she said, “More than once we just have a no-show.”

Ms. Marsh has been testing Dr. B. and said this saved her staff the hassle of calling a waiting list from other customers to quickly fill the open spaces. With Dr. B she said, “I know they at least call what we think is the right group of people to get these shots so we never have to waste any.”

Dr. B only disclosed a few details about which providers have expressed interest in using its platform. Apart from the fact that the providers are based in 30 states and include doctors’ offices, pharmacies, and medical departments of large academic institutions.

The company collects sensitive personal information, which it promises to strictly protect, even though the data is not protected by the federal health privacy law known as HIPAA, as the company is not itself a medical service provider.

When asked about his long-term plans for the company, Mr Massoumi declined, noting that the vaccination race was not going to end anytime soon.

“Right now we just want the vaccines to be allocated in the best possible way,” he said. “I can’t think of a better way of spending money on solving the pandemic. So we’re just bowing our heads and focusing on it.”

Categories
Business

J&J board member says 20 million Covid vaccine doses might be delivered by the tip of March

According to Dr. Johnson & Johnson board member Mark McClellan expects the company to have 20 million doses by the end of March as the US is just one step away from adding a third safe and effective vaccine to its arsenal.

“There will be a ramp-up, so 4 million doses are expected next week, rising in March, with 20 million doses dispensed by the end of March,” the former FDA commissioner said in an interview Friday night on The News with Shepard Smith. ” “So that’s 20 million people who are fully vaccinated because it’s just one dose of the vaccine.”

A panel of advisors to the Food and Drug Administration unanimously voted late Friday to recommend Johnson & Johnson’s single-dose shot for approval for emergency use. The FDA will decide on Saturday whether the vaccine will be approved. A recommendation from advisors to the Centers for Disease Control and Prevention would enable three to four million doses to be delivered next week.

McClellan told The News with Shepard Smith that the addition of the J&J vaccine will take the US a big step forward in fighting the coronavirus pandemic and protecting millions of people from the virus.

“That comes on top of some additions to the Pfizer and Moderna vaccine offering. They expect almost 90 million, 100 million doses … it’s a two-dose vaccine, but it all adds up to that we can get this far. ” At least 100 million people here in the US had been vaccinated by the end of March, “said McClellan, a health policy expert at Duke University.

Nationwide, average daily cases, hospitalizations and deaths have been going down for weeks, but Rochelle Walensky, director of the Centers for Disease Control and Prevention, said recent declines could flatten out.

“We may be through with the virus, but the virus clearly isn’t through with us,” Walensky said. “We cannot take it easy or give in to a false sense of security that the worst pandemic is behind us. Not now, not when mass vaccination is so close.”

The CDC director added that we may begin to see the effects of the new, contagious variants of Covid that are spreading across the country. McClellan agreed with Walensky, warning that “we should be concerned” when it comes to the new variants, but doubled the importance of vaccinations.

“The good news is that the vaccines offer really strong protection against the variants. The best way to contain the variants is to get as many people as possible vaccinated as soon as possible,” said McClellan.

Categories
Health

We want extra Covid vaccine doses and it must be simpler to get them, state and native well being officers say

People wearing protective masks wait in line to receive a dose of the Pfizer-BioNTech Covid-19 vaccine at a major vaccination site in Sacramento, California on Thursday, February 4, 2021.

David Paul Morris | Bloomberg | Getty Images

Scientists and health officials told Congress on Friday that the federal government must increase its supply of Covid-19 vaccine doses to streamline the process for ingestion.

These two changes are crucial if federal officials want to increase the number of people who receive the shots, scientists and public health officials who have testified before the Science, Space and Technology House Committee.

“Even people who are motivated and excited about the vaccine can be put off by the slightest friction in the system, whether it is complex logistics, inconvenience or confusing instructions,” said Dr. Alison Buttenheim, Scientific Director of the Center for Health Incentives and Behavioral Economics.

The hearing will take place when elected officials and health professionals address hesitation and disinformation related to the Covid-19 vaccine.

“Fix the simple stuff,” said Buttenheim. “In all honesty, it’s often easier to fix these problems than to change someone’s mind.”

Dr. Philip Huang, director and health department for the Dallas County Department of Health, said the county is trying to address “logistical and problematic factors” by providing online registration and phone banking for vaccine appointments, and by working with community leaders to register people for vaccinations of drive-through vaccination stations.

Keith Reed, assistant commissioner for the Oklahoma State Department of Health, said the state opened an extended timeframe to give residents more time to sign up for vaccine appointments.

“In order to vaccinate as many Oklahomans as possible, we opened the authorization to new priority groups before we fully vaccinated previous groups,” Reed said. “With this tactic we hope to extend the window of opportunity.”

Initiatives to reduce logistical barriers to those who wish to get vaccinations are particularly effective as vaccine supply in the US remains below community demand, according to panellists.

“Supply is the problem at this point,” said Huang. “We have over 650,000 people signed up on our waiting list to be vaccinated and the health department is receiving 9,000 doses a week.”

Health officials stressed that all Covid vaccines available in the US are effective at protecting people from serious illness, hospitalization and death. They urged people not to wait for the vaccination to get a particular brand of vaccine based on perceived effectiveness.

“The best vaccine is the one you can get tomorrow,” said Buttenheim.

Categories
Business

Winter storm delays shipments of 6 million Covid vaccine doses in U.S.: Officers

On February 18, 2021, vehicles will be idle on Interstate Highway 35 heading south in Killeen, Texas.

Joe Raedle | Getty Images

Massive winter storms in the Midwest and Texas have delayed the delivery of 6 million doses of Covid-19 vaccine, affecting every US state, the nation’s leading health officials said on Friday.

The backlog equates to three days of late deliveries, Andy Slavitt, White House senior advisor on Covid’s response, said during a news conference.

“Many states have been able to cover some of this delay with existing inventory,” said Slavitt.

The late deliveries are due to three major weather-related throttling points in the vaccines distribution chain, he said. Delivery centers at UPS, FedEx and McKesson that have been hired to deliver the cans to the states have reported staff shortages.

Slavitt said her workers were “snowed in and unable to come to work to package the vaccines, administration kits and other supplies.”

Road closures have also held up delivery of the vaccines between manufacturing facilities and shipping centers. In addition, more than 2,000 vaccine distribution points cannot receive doses because they are in places that are hampered by power outages, he said.

Continue reading: Covid live updates: Scientists are pushing for an optimized vaccination process

Because of the strict cold chain requirements for storing the cans in extremely cold temperatures, it is better to withhold the shipments than to send them to places where the shots may expire if they cannot be administered within three days. He said the vaccines are “safe and sound sitting in our factories and hubs and ready to ship.”

“As weather conditions improve, we are already trying to clear that backlog,” Slavitt said, adding that 1.4 million cans will be shipped on Friday. He said the government expected “all residue cans will be delivered within the next week.”

“We assume that we can handle this backlog and the new production that goes online next week,” said Slavitt.

Ahead of Friday’s briefing, US officials raised the alarm that their vaccine shipments were delayed this week. The massive winter storm closed distribution centers, leaving millions of people in states like Texas, Louisiana and Mississippi without power.

The Chief Medical Officer of the White House, Dr. Anthony Fauci, warned Thursday that the power outages and winter storm in Texas are a “significant” problem for Covid-19 vaccine distribution this week. The Biden government is asking vaccination centers to extend their working hours and offer additional appointments in the coming days and weeks to catch up, Slavitt said on Friday.

“If we all work together, from the factory to the vaccines, we’ll make up for that in the coming week,” he said.

Slavitt announced Friday that the government is working with Florida and Pennsylvania to open five more vaccination centers.

Four of the five vaccination centers will be located in the cities of Jacksonville, Miami, Orlando and Tampa, Florida. The four locations can vaccinate a total of up to 12,000 people per day. The fifth center will be in Philadelphia and vaccinate 6,000 people a day.

Categories
Business

Tyson Meals begins vaccinating staff, however struggles to search out doses

When looking for access to Covid vaccines, large employers like Tyson Foods are no better off than many individual Americans. Tight supplies usually keep them waiting.

The meat processing company received its largest vaccine allocation this week and is vaccinating workers at its plants in Missouri, Illinois and Virginia. But there are only 1,000 cans in the three states.

Executives say they have received 25 to 50 doses at a time so far this month to vaccinate their occupational health workers and workers over 65

“We are not turning down opportunities to obtain vaccines for our team members,” said Tom Brower, senior vice president of health and safety, Tyson.

However, the options were limited. With 120,000 workers in two dozen states, the company has not been able to get anywhere near enough supplies to keep vaccination clinics on a large scale.

“We’re coming into these jurisdictions and asking for 1,000 or 1,500 doses,” said Dr. Daniel Castillo, chief medical officer of Matrix Medical Network, Tyson’s professional health care provider, who conducted on-site testing of the meat packer.

Even in states that are now providing access to vaccines for key workers, the uncertainty of vaccine supplies is hanging over large employers. The local health authorities cannot give them a schedule of when to get access.

“They don’t know how much they actually have to allocate to us sometimes. That’s part of the challenge of really not having that line of sight,” Castillo said.

Tyson and rival meat packers JBS and Smithfield Foods came under fire at their facilities at the start of the pandemic due to widespread Covid outbreaks. At Tyson’s pork processing plant in Iowa, managers were laid off after a probe found they had bet how many workers would get sick. Congress has launched an investigation into security vulnerabilities in meat packers. Tyson and the other companies are working with the probe.

According to the Food & Environment Reporting Network monitoring group, more than 12,500 Tyson employees have been infected with the coronavirus since the pandemic began. Tyson won’t confirm the numbers, but says the Covid-19 protocols he has been running have kept workers safe.

The company has worked with Matrix Medical on tests to contain potential outbreaks and put in place safety measures such as plastic partitions to reduce potential exposure on production lines. Last year they also expanded the on-site health clinics and launched a pilot program to provide no-copay basic care services as part of a longer-term initiative to improve the general health of workers.

While a number of companies are offering cash rewards to motivate workers to get the vaccine, Tyson has chosen to persuade its mostly Latin American and African American meat packers through an awareness campaign against the hesitation of the vaccine.

“We didn’t want to take the approach of contracting the vaccine. We really want to help team members make informed decisions about their own health care and safety,” said Brower.

It’s not the only big employer standing empty of competition to track down the vaccine doses. Amazon, Walmart, and others are calling on federal and state officials to provide access to on-site vaccinations and even contact vaccine manufacturers to secure supplies, which has had little success so far.

“If every road leads to the same place, which is a rare vaccine, it’ll be a challenge no matter which road,” Castillo said.

Companies don’t want to be seen as an attempt to cross the line – they argue that they can unburden the system for individuals by vaccinating their large employee populations. In the meantime, Tyson is giving employees four hours of paid time off to get a vaccine elsewhere if they can get an appointment.